Teneligliptin PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Teneligliptin PCD pharma franchise company in India, offering 6 Teneligliptin formulations in tablet form, including plain strengths and fixed-dose combinations. All are manufactured at WHO-GMP certified facilities with DCGI-approved compositions, giving partners an affordable and fast-moving anti-diabetic line.
What is Teneligliptin?
Teneligliptin is an oral anti-diabetic drug of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. By inhibiting the DPP-4 enzyme it prevents the breakdown of incretin hormones such as GLP-1, which increases glucose-dependent insulin secretion and suppresses glucagon release, lowering blood glucose. Its distinctive J-shaped structure gives it a long duration of action, and it is eliminated by both hepatic and renal routes. Compound data is available on PubChem.
Therapeutic Applications of Teneligliptin
Teneligliptin is used as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, either as monotherapy or, more commonly, added to metformin, sulfonylureas or SGLT2 inhibitors when glycaemic targets are not met. It is prescribed by diabetologists, endocrinologists, consulting physicians and general practitioners.
Why Teneligliptin is a High-Potential Molecule for Distributors
Teneligliptin won the Indian market on price rather than novelty. In a country where the overwhelming majority of diabetes patients fund their own lifelong treatment, a gliptin that costs a fraction of sitagliptin or vildagliptin reshapes prescribing habits fast, and it has become the default DPP-4 inhibitor across tier-2 and tier-3 towns. It also needs no dose adjustment in renal impairment, which is a real clinical advantage given how common diabetic kidney disease is here. For a distributor, that combination — affordable pricing, broad prescriber acceptance and permanent chronic demand — produces high unit volumes and reliable monthly reorders.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers genuine district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and a full promotional package including visual aids, samples, prescription pads, MR bags and doctor gifts. Over 1000+ partners across India work with us.
References
- PubChem – Teneligliptin compound record
- PubMed – clinical literature on Teneligliptin
- MedlinePlus – Diabetes Medicines
Our formulations of Teneligliptin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: